Le Lézard
Classified in: Health
Subjects: DIS, AVO, CFG, DEI

The Public Health Agency of Canada launches a national dementia awareness campaign to help reduce stigma


TORONTO, Jan. 17, 2022 /CNW/ - The Public Health Agency of Canada (PHAC) is launching its first national dementia awareness campaign during Alzheimer's Awareness Month in Canada, to reduce negative perceptions about  dementia and the people living with the condition. 

Uninformed attitudes and beliefs about dementia can result in stigma, which can affect people living with dementia, their loved ones, and caregivers.  Stigma can lead to social isolation, make people feel alone, and erode their sense of self-worth.

The PHAC campaign is supporting the implementation of Canada's first national dementia strategy: A Dementia Strategy for Canada: Together We Aspire and aims to educate and help Canadians better understand dementia and how best to support and interact with people living with the condition. The campaign also highlights the abilities of people living with dementia while breaking down negative perceptions, to make our communities more welcoming and supportive.

People living with dementia can continue to be active in their community and participate in activities they enjoy. Some may live independently and continue to work and care for their families for years after the first symptoms appear. As dementia progresses, people living with the condition may need more assistance with their daily tasks, but they continue to want to connect with others and experience emotions as we all do.

PHAC has partnered with author, broadcaster and science communicator Jay Ingram to be the English-speaking spokesperson and ambassador. Mr. Ingram wrote the book The End of Memory: a natural history of Alzheimer's and Aging, based on his personal and professional observations of the impact of dementia.

"I am honored to help shed some light on dementia because too often representations of people living with this condition focus only on the negative aspects which can create false assumptions, including underestimating their abilities. I find it important to build understanding of the reasons for behaviours a person living with dementia could display, especially because each story is different," says Jay Ingram.

"We are pleased to work with Jay Ingram as he continues his efforts to help demystify dementia for all Canadians. It is important to understand that depending on their symptoms, a person living with dementia can continue to do many things and each has their own lived experiences to share. By increasing knowledge about dementia, we will be more equipped to create communities that support them in staying engaged and feeling valued and included," says the Honourable Jean-Yves Duclos, Minister of Health.

François Morency, actor, comedian and TV personality, will be the French-speaking spokesperson and ambassador.

Highlights and statistics from PHAC

About the Public Health Agency of Canada

The Public Health Agency of Canada is part of the federal health portfolio. Its activities focus on preventing disease and injuries, responding to public health threats, promoting good physical and mental health, and providing information to support informed decision making.

For more information regarding PHAC, please visit www.canada.ca/en/public-health and for more information on Dementia, canada.ca/dementia

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: